Factors associated with local-regional recurrence after a negative sentinel node dissection: results of the ACOSOG Z0010 trial.
about
Management of the Positive Axilla in 2017Post-mastectomy radiotherapy benefits subgroups of breast cancer patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis.Feasibility and accuracy of sentinel lymph node biopsy in clinically node-positive breast cancer after neoadjuvant chemotherapy: a meta-analysis.Curative use of forequarter amputation for recurrent breast cancer over an axillary area: a case report and literature review.Sentinel lymph node metastasis after neoadjuvant treatment in breast cancer: Any size matters?Factors Influencing Non-sentinel Node Involvement in Sentinel Node Positive Patients and Validation of MSKCC Nomogram in Indian Breast Cancer Population.Sentinel node biopsy for breast cancer: past, present, and future.Is axillary lymph node clearance required in node-positive breast cancer?Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 RandomLocoregional Control According to Breast Cancer Subtype and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Undergoing Breast-conserving Therapy.Regional Disease Control in Selected Patients with Sentinel Lymph Node Involvement and Omission of Axillary Lymph Node Dissection.Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.Hypofractionation with no boost after breast conservation in early-stage breast cancer patients.Different Prognostic Implications of Residual Disease After Neoadjuvant Treatment: Impact of Ki 67 and Site of Response.The Controversy Regarding Margin Width in Breast Cancer: Enough is Enough
P2860
Q33752466-2DB0BF00-A367-43E7-9CF8-559A777101BEQ33946372-815EE189-F426-49BE-A911-7923C29F23EBQ34165928-18269394-D72E-4708-9C82-D3FD920D9156Q34582169-59CE1EE3-D704-4F5C-BA90-D9B0B2A29405Q36363622-71B60925-C37C-4A33-AC6A-BD8AD07E400DQ36734707-70CB3674-F936-4E94-95D7-7422B1173F01Q38068375-49B104DE-FC7C-46AF-B4C7-C2768FF5AE7CQ38264840-B7FFADA0-9847-4BA4-9412-52CD483D2677Q39500625-934B3FCC-957B-4478-9C89-A91A9E0376D8Q40382522-FB2E2AF7-5E7E-4845-81C6-A2446CAD1C70Q41484688-9F5A3B1E-B3F6-409E-BD82-1D20BAE2AB1EQ50220940-D608F138-4018-4426-99DA-C8F3DF653A4FQ53038613-58D43221-3433-46CC-A552-F4158F50E9B8Q54187504-CC7DAF11-517D-4262-A195-3BA9B70A6A56Q57304406-55DE9D6B-53C4-41C0-8944-320FF5DCEF78
P2860
Factors associated with local-regional recurrence after a negative sentinel node dissection: results of the ACOSOG Z0010 trial.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Factors associated with local- ...... lts of the ACOSOG Z0010 trial.
@en
Factors associated with local- ...... lts of the ACOSOG Z0010 trial.
@nl
type
label
Factors associated with local- ...... lts of the ACOSOG Z0010 trial.
@en
Factors associated with local- ...... lts of the ACOSOG Z0010 trial.
@nl
prefLabel
Factors associated with local- ...... lts of the ACOSOG Z0010 trial.
@en
Factors associated with local- ...... lts of the ACOSOG Z0010 trial.
@nl
P2093
P2860
P1433
P1476
Factors associated with local- ...... ults of the ACOSOG Z0010 trial
@en
P2093
A Marilyn Leitch
Armando E Giuliano
Charles E Cox
Elizabeth A Mittendorf
Judy C Boughey
Kelly K Hunt
Linda M McCall
Monica A Morrow
Pat W Whitworth
Peter D Beitsch
P2860
P304
P356
10.1097/SLA.0B013E3182654494
P407
P577
2012-09-01T00:00:00Z